← Назад

Hirschsprung disease

ORPHA:388DiseaseAutosomal dominant, Autosomal recessive, Multigenic/multifactorial, Not applicableChildhood, Infancy, Neonatal

Ассоциированные гены (14)

ATP7A
ATPase copper transporting alpha
Disease-causing germline mutation(s) in
OMIM: 300011
ABCD1
ATP binding cassette subfamily D member 1
Disease-causing germline mutation(s) in
OMIM: 300371
ERBB2
erb-b2 receptor tyrosine kinase 2
Disease-causing germline mutation(s) in
OMIM: 164870
ERBB3
erb-b2 receptor tyrosine kinase 3
Disease-causing germline mutation(s) in
OMIM: 190151
SMO
smoothened, frizzled class receptor
Disease-causing germline mutation(s) in
OMIM: 601500
RET
ret proto-oncogene
Disease-causing germline mutation(s) in
OMIM: 164761
ECE1
endothelin converting enzyme 1
Major susceptibility factor in
OMIM: 600423
EDN3
endothelin 3
Major susceptibility factor in
OMIM: 131242
EDNRB
endothelin receptor type B
Major susceptibility factor in
OMIM: 131244
GDNF
glial cell derived neurotrophic factor
Major susceptibility factor in
OMIM: 600837
NRTN
neurturin
Major susceptibility factor in
OMIM: 602018
SEMA3C
semaphorin 3C
Major susceptibility factor in
OMIM: 602645
SEMA3D
semaphorin 3D
Major susceptibility factor in
OMIM: 609907
SREBF1
sterol regulatory element binding transcription factor 1
Disease-causing germline mutation(s) in
OMIM: 184756

Фенотипы (19)

Очень частый (80–99%)6
HP:0002251Aganglionic megacolon
HP:0005214Intestinal obstruction
HP:0012719Functional abnormality of the gastrointestinal tract
HP:0002017Nausea and vomiting
HP:0002019Constipation
HP:0002027Abdominal pain
Частый (30–79%)5
HP:0001824Weight loss
HP:0003270Abdominal distention
HP:0011968Feeding difficulties
HP:0034754Bilious emesis
HP:6000224Delayed passage of meconium
Периодический (5–29%)8
HP:0002014Diarrhea
HP:0004322Short stature
HP:0004387Enterocolitis
HP:0031369Colon perforation
HP:0100806Sepsis
HP:0001531Failure to thrive in infancy
HP:0001510Growth delay
HP:0001561Polyhydramnios

Эпидемиология (6)

Prevalence at birth
1-5 / 10 000
Europe
Prevalence at birth
1-5 / 10 000
United States
Point prevalence
1-5 / 10 000
Europe
Point prevalence
1-5 / 10 000
Worldwide
Prevalence at birth
1-5 / 10 000
Taiwan, Province of China
Prevalence at birth
1-5 / 10 000
Worldwide

Лекарства и терапия

Источник: Open Targets Platform (в реальном времени)

Клинические исследования

Источник: ClinicalTrials.gov (в реальном времени)

Внешние ресурсы